NYSE:ACBAurora Cannabis Stock Price, Forecast & News

Aurora Cannabis' stock was trading at $10.3044 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ACB shares have increased by 17.2% and is now trading at $12.08. View which stocks have been most impacted by Coronavirus.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 4 sell ratings, 10 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Aurora Cannabis.

Aurora Cannabis is scheduled to release its next quarterly earnings announcement on Wednesday, September 9th 2020. View our earnings forecast for Aurora Cannabis.

Aurora Cannabis Inc (NYSE:ACB) issued its quarterly earnings data on Thursday, May, 14th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.53) by $0.21. The firm had revenue of $56.31 million for the quarter, compared to analysts' expectations of $46.93 million. Aurora Cannabis had a negative return on equity of 8.55% and a negative net margin of 442.62%. View Aurora Cannabis' earnings history.

Aurora Cannabis shares reverse split before market open on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 8th 2020. An investor that had 100 shares of Aurora Cannabis stock prior to the reverse split would have 8 shares after the split.

17 brokers have issued twelve-month price objectives for Aurora Cannabis' shares. Their forecasts range from $10.00 to $108.00. On average, they expect Aurora Cannabis' stock price to reach $25.23 in the next year. This suggests a possible upside of 108.9% from the stock's current price. View analysts' price targets for Aurora Cannabis.

News coverage about ACB stock has trended very negative on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aurora Cannabis earned a news impact score of -3.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news about Aurora Cannabis.

Aurora Cannabis saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 19,490,000 shares, a drop of 10.9% from the June 15th total of 21,870,000 shares. Based on an average trading volume of 10,100,000 shares, the days-to-cover ratio is presently 1.9 days. Approximately 17.4% of the company's stock are short sold. View Aurora Cannabis' Current Options Chain.

Some companies that are related to Aurora Cannabis include STADA Arzneimittel (STDAF), Cronos Group (CRON), USANA Health Sciences (USNA), Aphria (APHA), Tilray (TLRY), Canopy Rivers (RIV), Chromadex (CDXC), Mediwound (MDWD), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN), True Drinks (TRUU) and FitLife Brands (FTLF). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), HEXO (HEXO), NVIDIA (NVDA), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), Micron Technology (MU) and General Electric (GE).

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Aurora Cannabis' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include TRUE Private Wealth Advisors (0.00%).

ACB stock was sold by a variety of institutional investors in the last quarter, including TRUE Private Wealth Advisors.

Shares of ACB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ACB stock can currently be purchased for approximately $12.08.

Aurora Cannabis has a market capitalization of $1.37 billion and generates $215.10 million in revenue each year. The company earns $-219,670,000.00 in net income (profit) each year or ($2.64) on an earnings per share basis. Aurora Cannabis employs 2,779 workers across the globe.

The official website for Aurora Cannabis is auroramj.com.

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company can be reached via phone at 1-855-279-4652 or via email at [email protected]